Inbiomotion

Developer of biomarkers to predict bone metastasis in cancer patients

placeBarcelona, Catalonia, Spain calendar_todayFounded 2010 groups10 employees language inbiomotion.com

Social engagement

Social engagement: 1K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

6 investors on record; lead investors include Ysios Capital, Caixa Capital Risc, Alta Life Sciences.

Investor typeCountShare
Venture capital350%
Other / undisclosed350%

Recent activity

25 May 2026
Event
ASCO 2026 Annual Meeting
21 May 2026
Partnership
HJ HyupJin
27 Mar 2026
Event
European Breast Cancer Conference
Coming soon